Amgen Employees Press 9th Circ. To Revive ERISA Action
Employee shareholders asked the Ninth Circuit on Friday to revive their putative class action accusing Amgen Inc. of misrepresenting sales growth estimates for two of its drugs amid safety concerns —...To view the full article, register now.
Already a subscriber? Click here to view full article